1. Home
  2. PCRX vs GFR Comparison

PCRX vs GFR Comparison

Compare PCRX & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.17

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Greenfire Resources Ltd.

GFR

Greenfire Resources Ltd.

BUY

Current Price

$5.99

Market Cap

924.7M

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
PCRX
GFR
Founded
2006
2018
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
924.7M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
PCRX
GFR
Price
$25.17
$5.99
Analyst Decision
Buy
Buy
Analyst Count
9
3
Target Price
★ $30.00
$7.75
AVG Volume (30 Days)
464.2K
★ 1.4M
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 107.44
N/A
EPS
★ 0.19
N/A
Revenue
★ $541,533,000.00
N/A
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.69
$99.34
P/E Ratio
$131.63
★ $4.33
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$4.15
52 Week High
$27.66
$7.16

Technical Indicators

Market Signals
Indicator
PCRX
GFR
Relative Strength Index (RSI) 49.83 45.88
Support Level $24.61 $5.54
Resistance Level $25.17 $6.09
Average True Range (ATR) 0.81 0.27
MACD 0.03 -0.07
Stochastic Oscillator 68.40 27.95

Price Performance

Historical Comparison
PCRX
GFR

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.

Share on Social Networks: